Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Molnupiravir (MK-4482/EIDD-2801) inhibits SARS-CoV-2 replication in Syrian Hamster Model Dr. Kamal Kant Kohli25 Jan 2022 11:04 AM ISTAn effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in...
Strides Pharma, Medicines Patent Pool ink pact to commercialize molnupiravir for global markets Ruchika Sharma24 Jan 2022 9:00 AM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has recently announced its partnership with Medicines Patent Pool (MPP)...
Anti COVID-19 Drug Without Side Effects Being Developed in India: CDRI Medical Dialogues Bureau22 Jan 2022 4:35 PM ISTCDRI director Prof Tapas Kundu said: "CDRI is working round-the-clock to develop drugs that can help in treating all variants of Covid-19, besides...
Laurus Labs inks pact with MPP to manufacture molnupiravir Medical Dialogues Bureau22 Jan 2022 3:52 PM ISTNew Delhi: Drug firm Laurus Labs on Friday said it has inked a pact with Geneva-based MPP (Medicine Patient Pool) for manufacturing the oral COVID-19...
Natco Pharma inks pact with MPP to sell Molnupiravir capsules Dr. Divya Colin22 Jan 2022 3:35 PM ISTNatco said with this licence agreement it can manufacture and sell Molnupiravir capsules 200 mg for Indian market, which will be sold under brand name...
Biophore India gets MPP licence to market molnupiravir Dr. Divya Colin22 Jan 2022 3:14 PM ISTNew Delhi: Biophore India Pharmaceuticals on Thursday said it has received licences from Medicines Patent Pool (MPP) on behalf of originator company...
Merck to supply 3 million doses of molupiravir to UNICEF Dr. Divya Colin20 Jan 2022 6:02 PM IST Merck , known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced the signing of a long-term supply agreement...
Pfizer oral COVID pill Paxlovid approved in Canada Dr. Divya Colin18 Jan 2022 4:33 PM ISTNew Delhi: Canada on Monday approved Pfizer Inc's oral antiviral treatment for mild to moderate cases of COVID-19 in adults, but said global supply...
Molnupiravir harms offset stated benefits of the drug, reiterates ICMR Lalhmangaihkimi14 Jan 2022 3:52 PM ISTNew Delhi: The Indian Council of Medical Research (ICMR) is taking another strong stand against the antiviral drug, Molnupiravir for the treatment of...
Molnupiravir Blocks SARS-CoV-2 Transmission in Ferrets Dr. Kamal Kant Kohli14 Jan 2022 11:19 AM ISTThe coronavirus disease (COVID)-19 pandemic is exerting a global impact on human health. Interrupting widespread community transmission is paramount...
10.01.2022 Top Health News Roshni Dhar10 Jan 2022 7:29 PM ISTHere are todays Top Health News India reports over 1.79 lakh new cases; Omicron tally crosses 4k-markCovid- 19 threat continues to...
